Literature DB >> 31656047

Donor origin CAR19 T cell infusion for B-ALL relapsed after allogeneic hematopoietic stem cell transplantation.

Xiaofei Yang1,2,3, Haiping Dai1,2,3, Liqing Kang4,5, Changju Qu1,2,3, Zheng Li1,2,3, Jia Yin1,2,3, Huiying Qiu1,2,3, Chengcheng Fu1,2,3, Yue Han1,2,3, Zhengming Jin1,2,3, Xiao Ma1,2,3, Xiamin Zhu1,2,3, Lei Yu4,5, Depei Wu1,2,3, Xiaowen Tang1,2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31656047     DOI： 10.1002/hon.2682

Source DB:  PubMed          Journal:  Hematol Oncol        ISSN： 0278-0232            Impact factor:   5.271


× No keyword cloud information.
  3 in total

1.  Relation between auditory difficulties and bortezomib-induced peripheral neuropathy in multiple myeloma: a single-center cross-sectional study.

Authors:  Fabrice Giraudet; Marie Selvy; Nicolas Kerckhove; Bruno Pereira; Fantine Barreau; Daniel Nguyen; Jérôme Busserolles; Aurélie Cabrespine; Carine Chaleteix; Martin Soubrier; Jacques-Olivier Bay; Richard Lemal; David Balayssac
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-01-31       Impact factor: 2.503

2.  Identification of the Predictive Models for the Treatment Response of Refractory/Relapsed B-Cell ALL Patients Receiving CAR-T Therapy.

Authors:  Jingxian Gu; Sining Liu; Wei Cui; Haiping Dai; Qingya Cui; Jia Yin; Zheng Li; Liqing Kang; Huiying Qiu; Yue Han; Miao Miao; Suning Chen; Shengli Xue; Ying Wang; Zhengming Jin; Xiaming Zhu; Lei Yu; Depei Wu; Xiaowen Tang
Journal:  Front Immunol       Date:  2022-03-17       Impact factor: 7.561

3.  Case Report: Successful Chimeric Antigen Receptor T Cell Therapy in Haploidentical-Allogeneic Stem Cell Transplant Patients With Post-Transplant Lymphoproliferative Disorder.

Authors:  Nan Yan; Na Wang; Peiling Zhang; Gaoxiang Wang; Xia Mao; Dan Peng; Dong Kuang; Liting Chen; Li Zhu; Jianfeng Zhou; Yicheng Zhang; Yang Cao
Journal:  Front Oncol       Date:  2021-07-22       Impact factor: 6.244
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.